Vogt‐Koyanagi‐Harada disease in pregnancy: Case report and review of 32 patients in the literature

Key Clinical Message Systemic prednisolone including steroid pulse therapy would be safe in 32 pregnant women, who developed Vogt‐Koyanagi‐Harada disease in the literature. Prednisolone administration would be shortened by monitoring of serous retinal detachment with optical coherence tomography. Abstract A 30‐year‐old woman in 31 weeks of pregnancy with metamorphopsia and headache was diagnosed Vogt‐Koyanagi‐Harada disease. She underwent steroid pulse therapy and oral prednisolone 20 mg daily for 3 weeks until complete resolution of serous retinal detachment monitored by optical coherence tomography. Oral prednisolone was tapered and discontinued until uneventful delivery.